OptimizeRx Corp — Director's Dealing 2024

May 7, 2024

SEC Form 4/A — Form 4/A

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2024-02-15

Reporting Person: Silvestro Stephen L (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-02-15	Common Stock	A	7750	—	Acquired	16906	Direct

Footnotes

F1: This Form 4 as originally filed reported in Table 1 a grant of Common Stock on March 15, 2024. However, this transaction occurred on February 15, 2024.

F2: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on February 15, 2025, which is the first anniversary of the date of grant.

F3: A prior Form 4 filed by the Reporting Person failed to carry-forward previously owned shares, resulting in an understatement of the shares beneficially owned by the Reporting Person. The total amount beneficially owned has been adjusted to correct such inadvertent understatement.